PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A951. A total of 3 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $47,000 | -65.2% | 228,500 | -20.7% | 0.00% | -100.0% |
| Q2 2019 | $135,000 | +7.1% | 288,000 | +0.5% | 0.00% | 0.0% |
| Q1 2019 | $126,000 | +240.5% | 286,600 | +140.8% | 0.00% | – |
| Q4 2018 | $37,000 | -71.3% | 119,000 | -33.2% | 0.00% | -100.0% |
| Q3 2018 | $129,000 | +616.7% | 178,100 | +314.2% | 0.00% | – |
| Q2 2018 | $18,000 | +500.0% | 43,000 | +616.7% | 0.00% | – |
| Q1 2018 | $3,000 | – | 6,000 | +1100.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 500 | -83.9% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 3,100 | +210.0% | 0.00% | – |
| Q2 2017 | $1,000 | -85.7% | 1,000 | -80.8% | 0.00% | – |
| Q1 2017 | $7,000 | +600.0% | 5,200 | +246.7% | 0.00% | – |
| Q3 2016 | $1,000 | -85.7% | 1,500 | -87.0% | 0.00% | – |
| Q2 2016 | $7,000 | -80.0% | 11,500 | -36.1% | 0.00% | – |
| Q2 2015 | $35,000 | 0.0% | 18,000 | -7.2% | 0.00% | -100.0% |
| Q1 2015 | $35,000 | +775.0% | 19,400 | +823.8% | 0.00% | – |
| Q4 2014 | $4,000 | -98.6% | 2,100 | -98.3% | 0.00% | -100.0% |
| Q3 2014 | $296,000 | -63.4% | 122,200 | -44.9% | 0.01% | -58.3% |
| Q2 2014 | $809,000 | -25.7% | 221,700 | -6.8% | 0.01% | -33.3% |
| Q1 2014 | $1,089,000 | +309.4% | 237,800 | +247.7% | 0.02% | +350.0% |
| Q4 2013 | $266,000 | -31.8% | 68,400 | -20.6% | 0.00% | -42.9% |
| Q3 2013 | $390,000 | +106.3% | 86,100 | +123.6% | 0.01% | +40.0% |
| Q2 2013 | $189,000 | – | 38,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 181 | $9,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,500 | $1,000 | 0.00% |